Tuberculosis (TB) and depression act synergistically via social, behavioral, and biological
mechanisms to magnify the burden of disease. Clinical depression is a common, under …

Background There is increasing evidence that the substantial global burden of disease for
tuberculosis unfolds in concert with dimensions of common mental disorders. Person …

Little is known about the impact of comorbidities on multidrug resistant (MDR) and
extensively drug resistant (XDR) tuberculosis (TB) treatment outcomes. We aimed to …

Background People with drug-resistant tuberculosis (DR-TB) are known to suffer from many
mental-health disorders. This study aims to describe the proportion of patients diagnosed …

Depression is the leading cause of disability worldwide. 1 Tuberculosis is the leading cause
of death by a single infectious agent. 2 The prevalence of depression could be as high as …

Background and objectives People receiving treatment for multidrug-resistant tuberculosis
(MDR-TB) have high rates of depression. Psychosocial support in general, and treatments …

Objectives Tuberculosis (TB) remains prevalent despite the availability of effective anti-TB
medications, and accumulating evidence suggests a high rate of mental disorders in people …

BACKGROUND AND OBJECTIVES: Depression is likely to be a factor in the low global rates
of successful treatment for multidrug-resistant tuberculosis (MDR-TB) due to poor adherence …

Introduction: Depression and anxiety among tuberculosis (TB) patients can adversely affect
TB treatment adherence and completion. Aim: We studied whether integrating mental health …

Setting: Multidrug-resistant tuberculosis (MDR-TB) patients in the national TB treatment
programme of Nepal. Objective: To estimate the prevalence of depression and anxiety in …